Compare MetLife Inc. Common Stock (MET) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MetLife Inc. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? MetLife Inc. Common Stock trades at $98.67 (market cap $62.58B), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: MetLife Inc. Common Stock is far larger — about 36× Nuvation Bio Inc. Class A Common Stock's market cap, and MetLife Inc. Common Stock pays a 2.41% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MetLife Inc. Common Stock for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| MET | NUVB | |
|---|---|---|
Market Cap | $62.58B | $1.74B |
Volume | 3,009,466 | 9,289,619 |
Sector | Financials | Health |
52-Week High | $99.95 | $9.54 |
52-Week Low | $67.70 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $83.50B | $1.33B |
Dividend Yield | 2.41% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MetLife Inc. Common Stock
MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
